Clinical observations after neural transplantation in Parkinson's disease (Q34120746)

31 July 2017

1 reference

title

Clinical observations after neural transplantation in Parkinson's disease (English)

1 reference

31 July 2017

1 reference

Lindvall O

1

1 reference

31 July 2017

Hagell P

series ordinal

2

1 reference

31 July 2017

publication date

1 January 2000

1 reference

Progress in Brain Research

31 July 2017

published in

1 reference

31 July 2017

volume

127

1 reference

31 July 2017

page(s)

299-320

1 reference

Chronic treatment with levodopa and/or selegiline does not affect behavioral recovery induced by fetal ventral mesencephalic grafts in unilaterally 6-hydroxydopamine-lesioned rats

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

A comparison of the behavioural effects of embryonic nigral grafts in the caudate nucleus and in the putamen of marmosets with unilateral 6-OHDA lesions

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

The metabolic anatomy of tremor in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Preliminary Voice and Speech Analysis Following Fetal Dopamine Transplants in 5 Individuals With Parkinson Disease

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Neural Tissue Xenotransplantation: What Is Needed Prior to Clinical Trials in Parkinson's Disease?

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

The behavioural and motor consequences of focal lesions of the basal ganglia in man.

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Tirilazad Mesylate Increases Dopaminergic Neuronal Survival in thein OculoGrafting Model

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

The effect of chronic L-dopa treatment on the recovery of motor function in 6-hydroxydopamine-lesioned rats receiving ventral mesencephalic grafts

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Quantification of motor slowness in Parkinson's disease: Correlations between the tapping test and single joint ballistic movement parameters

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Functional and anatomical reconstruction of the 6-hydroxydopamine lesioned nigrostriatal system of the adult rat.

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Dopamine neurons grafted unilaterally to the nucleus accumbens affect drug-induced circling and locomotion

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

The apomorphine test in parkinsonian syndromes

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Quality of life in patients with Parkinson's disease: development of a questionnaire

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Sequential intrastriatal grafting of allogeneic embryonic dopamine-rich neuronal tissue in adult rats: Will the second graft be rejected?

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Dopamine-rich grafts ameliorate whole body motor asymmetry and sensory neglect but not independent limb use in rats with 6-hydroxydopamine lesions

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Electrophysiological characteristics of cells within mesencephalon suspension grafts

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Time-course of recovery of dopamine neuron activity during reinnervation of the denervated striatum by fetal mesencephalic grafts as assessed by in vivo voltammetry

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants: presurgical, and 1- and 2-year follow-up

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Clinical rating of dyskinesias in Parkinson's disease: use and reliability of a new rating scale

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Sequential bilateral transplantation in Parkinson's disease: effects of the second graft

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Is the SF-36 health survey questionnaire suitable as a self-report measure of the health status of older adults with Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Functional effects of striatal dysfunction in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Fetal grafting for Parkinson's disease: expression of immune markers in two patients with functional fetal nigral implants

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

The core assessment program for intracerebral transplantation

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Core assessment program for intracerebral transplantations (CAPIT)

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Transplantation of Fetal Mesencephalic Tissue in Parkinson's Patients

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Slowness of movement in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group.

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Timed tests in Parkinson's disease evaluation.

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Do we know what global ratings of health-related quality of life measure?

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Tirilazad Mesylate Improves Survival of Rat and Human Embryonic Mesencephalic Neuronsin Vitro

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon.

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Psychiatric status after human fetal mesencephalic tissue transplantation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Clinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination.

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

General cognitive ability following unilateral and bilateral fetal ventral mesencephalic tissue transplantation for treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Implants of Polymer-Encapsulated Genetically Modified Cells Releasing Glial Cell Line-Derived Neurotrophic Factor Improve Survival, Growth, and Function of Fetal Dopaminergic Grafts

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Caspase inhibition reduces apoptosis and increases survival of nigral transplants

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Levodopa-induced dyskinesias in parkinsonian monkeys: relationship to extent of nigrostriatal damage

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Distinguishing between quality of life and health status in quality of life research: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Factor analysis of the motor section of the unified Parkinson's disease rating scale during the off-state.

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Conceptualizing and defining outcome

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Rating impairment and disability in Parkinson's disease: evaluation of the Unified Parkinson's Disease Rating Scale

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Smartbombs and cloaking devices

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Chronic levodopa impairs the recovery of dopamine agonist-induced rotational behavior following neural grafting

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

Constructing a new nigrostriatal pathway in the Parkinsonian model with bridged neural transplantation in substantia nigra.

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity

1 reference

https://api.crossref.org/works/10.1016/S0079-6123(00)27014-3

7 January 2021

10.1016/S0079-6123(00)27014-3

Identifiers

DOI

1 reference

31 July 2017

1 reference